Share

    


In This Section

Home / Learn / Cancer Types / Breast Cancer / Breast Cancer Project Advisory Committees

Breast Cancer Project Advisory Committees

Addressing Challenges in Oral Therapies for HR+, HER2- Breast Cancer

Rachel Yung
Rachel L. Yung, MD
Associate Professor
Clinical Research Division, Fred Hutch Cancer Center
Seattle, WA

Rachel Yung, MD, is a medical oncologist at the Clinical Research Division of the Fred Hutch Cancer Center in Seattle, Washington. Dr Yung studies new ways to treat breast cancer. She leads clinical trials that aim to identify unique signatures on cancer cells that could help improve outcomes and reduce side effects from treatments such as chemotherapy and hormone therapy. D. Yung also studies how lifestyle can influence the quality of care, patient-reported outcomes, prevention and survivorship of cancer.

Dr. Yung completed research and clinical fellowship training in medical oncology at Dana‐Farber Cancer Institute, Brigham and Women’s Hospital, Massachusetts General Hospital in Boston, Massachusetts, and internal medicine residency at Beth Israel Deaconess Medical Center in New York City, New York. She received her medical degree from Harvard Medical School in Boston, Massachusetts.

Eliminating Disparities in Access to Quality Cancer Care in African American Women with Triple Negative Breast Cancer

Rachel Yung
Rachel L. Yung, MD
Associate Professor
Clinical Research Division, Fred Hutch Cancer Center
Seattle, WA

Rachel Yung, MD, is a medical oncologist at the Clinical Research Division of the Fred Hutch Cancer Center in Seattle, Washington. Dr Yung studies new ways to treat breast cancer. She leads clinical trials that aim to identify unique signatures on cancer cells that could help improve outcomes and reduce side effects from treatments such as chemotherapy and hormone therapy. D. Yung also studies how lifestyle can influence the quality of care, patient-reported outcomes, prevention and survivorship of cancer.

Dr. Yung completed research and clinical fellowship training in medical oncology at Dana‐Farber Cancer Institute, Brigham and Women’s Hospital, Massachusetts General Hospital in Boston, Massachusetts, and internal medicine residency at Beth Israel Deaconess Medical Center in New York City, New York. She received her medical degree from Harvard Medical School in Boston, Massachusetts.

Making Sense of the Evolving Standards of Care for Advanced HER2+ Breast Cancer

Rachel Yung
Rachel L. Yung, MD
Associate Professor
Clinical Research Division, Fred Hutch Cancer Center
Seattle, WA

Rachel Yung, MD, is a medical oncologist at the Clinical Research Division of the Fred Hutch Cancer Center in Seattle, Washington. Dr Yung studies new ways to treat breast cancer. She leads clinical trials that aim to identify unique signatures on cancer cells that could help improve outcomes and reduce side effects from treatments such as chemotherapy and hormone therapy. D. Yung also studies how lifestyle can influence the quality of care, patient-reported outcomes, prevention and survivorship of cancer.

Dr. Yung completed research and clinical fellowship training in medical oncology at Dana‐Farber Cancer Institute, Brigham and Women’s Hospital, Massachusetts General Hospital in Boston, Massachusetts, and internal medicine residency at Beth Israel Deaconess Medical Center in New York City, New York. She received her medical degree from Harvard Medical School in Boston, Massachusetts.

Quality Improvement in Breast Cancer Through BRCA Testing

Rachel Yung
Rachel L. Yung, MD
Associate Professor
Clinical Research Division, Fred Hutch Cancer Center
Seattle, WA

Rachel Yung, MD, is a medical oncologist at the Clinical Research Division of the Fred Hutch Cancer Center in Seattle, Washington. Dr Yung studies new ways to treat breast cancer. She leads clinical trials that aim to identify unique signatures on cancer cells that could help improve outcomes and reduce side effects from treatments such as chemotherapy and hormone therapy. D. Yung also studies how lifestyle can influence the quality of care, patient-reported outcomes, prevention and survivorship of cancer.

Dr. Yung completed research and clinical fellowship training in medical oncology at Dana‐Farber Cancer Institute, Brigham and Women’s Hospital, Massachusetts General Hospital in Boston, Massachusetts, and internal medicine residency at Beth Israel Deaconess Medical Center in New York City, New York. She received her medical degree from Harvard Medical School in Boston, Massachusetts.

Assessing the Status of BRCA Testing and the Challenges Faced by Cancer Care Teams: 2023 BRCA Testing Reassessment Survey

Rachel Yung
Rachel L. Yung, MD
Associate Professor
Clinical Research Division, Fred Hutch Cancer Center
Seattle, WA

Rachel Yung, MD, is a medical oncologist at the Clinical Research Division of the Fred Hutch Cancer Center in Seattle, Washington. Dr Yung studies new ways to treat breast cancer. She leads clinical trials that aim to identify unique signatures on cancer cells that could help improve outcomes and reduce side effects from treatments such as chemotherapy and hormone therapy. D. Yung also studies how lifestyle can influence the quality of care, patient-reported outcomes, prevention and survivorship of cancer.

Dr. Yung completed research and clinical fellowship training in medical oncology at Dana‐Farber Cancer Institute, Brigham and Women’s Hospital, Massachusetts General Hospital in Boston, Massachusetts, and internal medicine residency at Beth Israel Deaconess Medical Center in New York City, New York. She received her medical degree from Harvard Medical School in Boston, Massachusetts.